Vitamin K status in relation to bone metabolism in patients with renal failure

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 504-508

  Małyszko, Jolanta ^a   Wołczyński, Sławomir ^b   Skrzydlewska, Elzbieta ^b   Małyszko, Jacek S ^b   Myśliwiec, Michał ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NONE

Author keywords

Continuous ambulatory peritoneal dialysis; Hemodialysis; Kidney transplantation; Renal failure; Vitamin K

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; COLECALCIFEROL; DEOXYPYRIDINOLINE; OSTEOCALCIN; OSTEONECTIN; PARATHYROID HORMONE; PHYTOMENADIONE; PROCOLLAGEN C PROTEINASE; VITAMIN K GROUP;

ADULT; AGE; AGED; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; PERITONEAL DIALYSIS; PRIORITY JOURNAL; VITAMIN K DEFICIENCY;

ADULT; ALKALINE PHOSPHATASE; BONE AND BONES; CALCIFEDIOL; CALCITRIOL; CALCIUM; COLLAGEN TYPE I; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; OSTEOCALCIN; OSTEONECTIN; PARATHYROID HORMONE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; VITAMIN K;

EID: 0036974677     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065287     Document Type: Article

References (16)

1. Vermeer C: Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990;266:625-636.
2. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G: Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452.
3. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9:1591-1595.
4. Szulc P, Chapuy MC, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769-1774.
5. Kohlmeier M, Saupe J, Shearer MJ, Schaefer K, Asmus G: Bone health of adult hemodialysis patients is related to vitamin K status: Kidney Int 1997;51:1218-1221.
6. Reichel H: No effect of vitamin K1 supplementation on biochemical bone markers in hemodialysis patients. Nephrol Dial Transplant 1999;14:249-250.
7. 1 (phylloquinone) in human serum by straight phase HPLC. Biomed Chromatogr 1987;2:79-88.
8. Hruska K: New concepts in renal osteodystrophy. Nephrol Dial Transplant 1998;13:2755-2761.
9. Knapen MHJ, Hamulyak K, Vermeer C: The effect of vitamin K supplementation on circulating osteocalcin (bone GLA protein) and urinary calcium excretion. Ann Intern Med 1989;111:1001-1005.
10. Orimo H, Fujita T, Onomura T, Inoue T, Kushida K, Shiraki M: Clinical evaluation of Ea-0167 (Menatetrenone) in the treatment of osteoporosis. Clin Eval 1992;20:45-100.
11. Knapen MHJ, Kon-Siong GJ, Hamulyak K, Vermeer C: Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int 1993;53:81-85.
12. Akiba T, Kurihara S, Tachibana K, Kuwahara M, Sakamoto H, Yoneshima H, Marumo F: Vitamin K (K) increased bone mass (BM) in hemodialysis patients (pts) with low turnover bone disease (LTOBD). J Am Soc Nephrol 1991;2:608.
13. Gyorffy B, El-Shakmak A, Vannay A, Szabo A, Reichel H: Vitamin K: effects on bone metabolism in experimental renal failure. Nephrol Dial Transplant 2001;6:A28.
14. Robert D, Jorgetti V, Leclerq M, Lacour B, Ulmann A, Bourdeau A, Drueke T: Does vitamin K excess induce ectopic calcifications in hemodialysis patients? Clin Nephrol 1985;24:300-304.
15. Knapen MHJ, Hellemons-Boode BSP, Lagenberg-Ledeboer M, Knottnerus JA, Hamulyak K, Price PA, Vermeer C: Effect of oral anticoagulant treatment on markers for calcium and bone metabolism. Haemostasis 2000;30:290-297.
16. Sage HE, Bornstein P: Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 1991;266:14831-14834.